Benzimidazoles, process for their preparation and use thereof as medicament

Biphenyl carboxamides

Small molecule inhibitors of rotamase enzyme activity

Inhibitors of proteins that bind phosphorylated molecules

Vanilloid receptor ligands and their use in treatments

Diaminopyrimidinecarboxamide derivative

Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes

Hydrazonopyrazole derivatives and their use as therapeutics

Heteroaromate OSC inhibitors

Urea derivatives as FLT-3 modulators

Serine protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Vanilloid receptor ligands and their use in treatments

Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors

3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors

Ansamycins having improved pharmacological and biological properties

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

Propane-1, 3-dione derivative

3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands

Inhibitors of hepatitis C virus NS3 protease

Pyrrolidine and thiazolidine compounds

Tyrosine kinase inhibitors

Substituted 3-carboxamido isoxazoles as kinase modulators

Piperizinones as modulators of chemokine receptor activity

Cyclic protein tyrosine kinase inhibitors

Substituted heteroaryl derivatives, compositions, and methods of use

Compounds which inhibit leukocyte adhesion mediated by VLA-4

4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide

Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them

Pharmaceutical compounds

Spiro and dispiro 1,2,4-trioxolane antimalarials

Substituted pyrazolyl compounds for the treatment of inflammation

Raf kinase inhibitors

Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same

Ophthalmic compositions for treating ocular hypertension

Protease inhibitors

Fredericamycin derivatives

Heterocyclic self-immolative linkers and conjugates

Novel herbicides

Positive allosteric modulators of the nicotinic acetylcholine receptor

Substituted piperidine compounds useful as modulators of chemokine receptor activity

PNA monomer and precursor

PNA monomer and precursor

Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss

Diamine derivatives

Amide derivatives

Compounds and methods of use

Monocyclic heterocycles as kinase inhibitors

Hetero-bridge substituted 8-arylquinoline pde4 inhibitors

Non-nucleoside reverse transcriptase inhibitors

Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use

New compounds

Diaminothiazoles

New compounds

Substituted hydroxyethylamine aspartyl protease inhibitors

Melanocortin receptor ligands

Piperidine compounds

Novel compounds

Substituted hydroxyethylamine aspartyl protease inhibitors

Quinazoline derivatives and pharmaceutical compositions containing them

Therapeutic compounds for treating dyslipidemic conditions

Tubulysin analogues

Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids

8-(biaryl)quinoline PDE4 inhibitors

Triazoles as farnesyl transferase inhibitors

Use of 1H-indol-3-yl-2-oxoacetamide compounds

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions

Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt

Capped pyrazinoylguanidine sodium channel blockers

Dipeptidyl peptidase-IV inhibitors

Quinoxalines useful as inhibitors of protein kinases

Pyrazole derivative

Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

Cyclic amine derivatives and methods of use

Protease inhibitors

Thrombopoietin mimetics

Caspase inhibitors and uses thereof

Benzoxazole compounds, process for producing the same and herbicides

Capped pyrazinoylguanidine sodium channel blockers

Tyrosine kinase inhibitors

Platelet ADP receptor inhibitors

Substituted oxindole derivatives as tyrosine kinase inhibitors

Novel anticancer compounds

Bicyclic heterocycles useful as serine protease inhibitors

Vanilloid receptor ligands and their use in treatments

Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same

Pesticidal pyridinecarboxamide derivatives

Phenyloxyalkanonic acid derivatives as hPPAR activators

Inhibitors of histone deacetylase

Heterocyclic amides with anti-tuberculosis activity

Five-membered cyclic compounds

Pyrrolidine compounds

Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors

Process for the preparation of morpholine derivatives and intermediates therefore

Azetidine derivatives as CCR-3 receptor antagonists

O-cyclopropyl-carboxanilides and their use as fungicides

Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Substituted indoles and their use as hcv inhibitors

Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor

Pyrrolidine-3,4-dicarboxamide derivatives

Serine protease inhibitors

Thiadiazole compounds and use thereof

Inhibitors of glutaminyl cyclase

Amino benzothiazole compounds with NOS inhibitory activity

Ether derivatives

Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors

β2-adrenergic receptor agonists

Diaminopyrimidines as P2Xand P2Xantagonists

5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors

Ion channel modulators

Polymorph of a pharmaceutical

Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions

Biaryl heterocyclic compounds and methods of making and using the same

Amino-benzazoles as P2Yreceptor inhibitors

2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses

Glucagon antagonists/inverse agonists

antibacterial agents

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Carboxylic acid amides, the preparation thereof and their use as medicaments

Oxidized thioether derivatives

Urea derivatives as PDGFR modulators

Amide compounds as ion channel ligands and uses thereof

Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof

Indazole derivatives as inhibitors of hormone sensitive lipase

Polymorphic form B2 of ziprasidone base

Substituted heterocyclic compounds

Bicyclic compounds and compositions as PDF inhibitors

Substituted spiro azabicyclics as modulators of chemokine receptor activity

Urea derivatives as C-kit modulators

3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

Amide compounds as ion channel ligands and uses thereof

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Substituted benzazoles and methods of their use as inhibitors of Raf kinase

Ligands of melanocortin receptors and compositions and methods related thereto

Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)

Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them

Hydroxamates as therapeutic agents

Hydrogenation of precursors to thiazolidinedione antihyperglycemics

Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Substituted Azetidine compounds, their preparation and use as medicaments

Herbicides

Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase

Acylaminothiazole derivatives, preparation and therapeutic use thereof

Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Vanilloid receptor ligands and their use in treatments

Therapeutic heterocyclic compounds

Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors

Nicotinamide derivatives useful as p38 inhibitors.

Modulators of ATP-Binding Cassette transporters

Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth

Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use

3-Thia-4-arylquinolin-2-one potassium channel modulators

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Vanilloid receptor ligands and their use in treatments

Pyrazinone derivatives

Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Amide derivatives as glycogen synthase kinase 3-β inhibitors

Integrin expression inhibitor

Selective NPY (Y5) antagonists

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide

Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors

Amide derivatives as PDGFR modulators

Amide derivatives as FLT-3 modulators

Prodrugs of potassium channel inhibitors

Modulators of the glucocorticoid receptor and method

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Amide derivatives as C-KIT modulators

Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers

Amine compounds and use thereof

Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade

Substituted indoles

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Urea derivatives as ABL modulators

Isoxazolyl urea derivatives as kinase modulators

Retinoic acid mimetic anilides

Benzimidazoles and analogs thereof as antivirals

N-substituted benzene sulfonamides

Herbicides

Cyclic compound, process for producing the same, and pest control agent

5-Aryltetrazole compounds and uses thereof

Indole derivatives

Substituted bicyclic derivatives for the treatment of abnormal cell growth

Ethylene diamine derivatives and their use as orexin-receptor antagonists

5-Aryltetrazoles compounds and compositions thereof

Compounds, compositions and methods

Vanilloid receptor ligands and their use in treatments

Substituted indoles

2-Acylaminothiazole derivative or salt thereof

Novel compounds

Thiazole derivatives

Substituted arylamine derivatives and methods of use

Inhibitors of hepatitis C virus NS3/NS4a serine protease

Conjugated small molecules

Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

HIV protease inhibiting compounds

Amide derivatives as ABL modulators

LFA-1 antagonist compounds

Quinoxalinones

Organophotoreceptor with charge transport material having a thiiranyl group

N3 alkylated benzimidazole derivatives as MEK inhibitors

Inhibitors of interleukin-1beta converting enzyme

Processes for preparation of ziprasidone

Novel crystalline forms of ziprasidone hydrochloride

Amide thiadiazole inhibitors of plasminogen activator inhibitor-1

Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same

Selective NPY (Y5) antagonists

Biaromatic ligand activators of PPARγ receptors

Benzyl sulfonamide derivatives

Medical devices employing triazine compounds and compositions thereof

Aryl sulfonamides

Compositions useful as inhibitors of voltage-gated sodium channels

Quinolines and pharmaceutical compositions thereof

Amide compounds and medications containing the same

Amide compounds and medications containing the same technical field

Inhibitors of akt activity

Benzothiazole compositions and their use as ubiquitin ligase inhibitors

Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

Benzylcycloalkyl amines as modulators of chemokine receptor activity

Urea thiadiazole inhibitors of plasminogen activator inhibior-1

Compounds and methods of use

Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors

Piperazine derivatives and their use as modulators of nuclear hormone receptor function

Medical devices employing triazine compounds and compositions thereof

2-imino-1,3-thiazine derivatives

3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis

8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Diamine derivatives

5-phenylthiazole derivatives and use as Pi3 kinase inhibitors

Substituted acid derivatives useful as antidiabetic and antiobesity agents and method

Heterocyclic compounds and methods of making and using thereof

κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative

Compounds that modulate PPAR activity and methods of preparation

Methionine aminopeptidase inhibitor

Therapeutic compounds for treating dyslipidemic conditions

Compounds having βadrenergic receptor agonist and muscarinic receptor antagonist activity

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Quinoline inhibitors of cGMP phosphodiesterase

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

Medical devices employing triazine compounds and compositions thereof

Alpha-ketoamide derivatives as cathepsin k inhibitors

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

Compounds that modulate PPAR activity and methods of preparation

Rosiglitazone edisylates and their use as antidiabetics

Chemical compounds

Pyrimidine-2,4,6-trione metalloproteinase inhibitors

Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands

Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain

Anti-infective agents

Amide derivatives and methods of their use

Aromatic sulfone hydroxamic acids and their use as protease inhibitors

4-Substituted quinolines as antitumor agents

N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use

Antipruritics

Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

Iminothiazolidinones as inhibitors of HCV replication

Activator of peroxisome proliferator-activated receptor delta

DPP IV inhibitors

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Therapeutic quinolone compounds with 5-ht-antagonistic properties

Aspartic protease inhibitors

5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2, 4-dione and pharmaceutical compositions comprising the same

Novel adamantane derivatives

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof

Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

Gamma secretase inhibitors

HMG-CoA reductase inhibitors and method

Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient

Androgen receptor antagonists

Androgen receptor antagonists

Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Therapeutic quinolone compounds with 5-ht-antagonistic properties

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt

Modulators of LXR

Compounds effecting glucokinase

Capped pyrazinoylguanidine sodium channel blockers

Potassium channel modulators

Dye-forming coupler and silver halide color photographic light-sensitive material

HIV protease inhibitors

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Modulators of peroxisome proliferator activated receptors (PPAR)

Aminoquinoline compounds

Compounds and uses thereof in modulating amyloid beta